-5%
Hepatitis B Vaccine (rDNA) is used to prevent Hepatitis B infection. It helps develop immunity by initiating a mild, non-illness-causing infection, stimulating the body’s immune system to produce protective antibodies.
The Hepatitis B Vaccine is a non-infectious recombinant DNA vaccine. It is a sterile suspension consisting of purified surface antigens from the hepatitis B virus. This antigen is obtained by culturing genetically engineered yeast cells (Saccharomyces cerevisiae), which carry the gene coding for the HBsAg. The HBsAg protein, produced in yeast cells, is purified through multiple physicochemical processes and then formulated as a suspension with the antigen adsorbed on aluminum hydroxide. No human-derived substances are used in the manufacturing process.